首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Synthesis and biological evaluation of novel series of chalcone derivatives as inhibitors of eyclooxygenase and LPS-induced TNF-alpha with potent antioxidant properties
【24h】

Synthesis and biological evaluation of novel series of chalcone derivatives as inhibitors of eyclooxygenase and LPS-induced TNF-alpha with potent antioxidant properties

机译:新型查尔酮衍生物作为环氧乙烷加氧酶和LPS诱导的TNF-α抑制剂具有强抗氧化性能的合成及生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

Novel series of chalcones were synthesized and were evaluated as possible anti-inflammatory agents targeting the eyclooxygenase-1 and 2 (COX-1 and 2), beta-glucu-ronidase, trypsin, and TNF-a. Amongst the tested chalcones the compound 4k was found to be most effective inhibitor of TNF-a exhibiting 85% inhibition activity (IC_50 = 0.1 muM). The compounds 4a, 4f, 41, and 4m were found to inhibit the COX-1 activity in as a range of 79.95-68.47% and COX-2 inhibition ranging 84.45-74.77%. The compounds 41 (81.71%) and 4f (72.10%) were found to be excellent inhibitors of trypsin and beta-glucuronidase, respectively.
机译:合成了新的查耳酮系列,并被评估为可能针对靶向环氧乙烷加氧酶-1和2(COX-1和2),β-葡萄糖苷酸酶,胰蛋白酶和TNF-α的抗炎药。在测试的查耳酮中,发现化合物4k是表现出85%抑制活性(IC_50 = 0.1μM)的最有效的TNF-α抑制剂。发现化合物4a,4f,41和4m在79.95-68.47%的范围内抑制COX-1活性,在84.45-74.77%的范围内抑制COX-2。发现化合物41(81.71%)和4f(72.10%)分别是胰蛋白酶和β-葡萄糖醛酸苷酶的优良抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号